Trials / Completed
CompletedNCT02193581
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging: the MDS (Melanoma Detecting System)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Orlucent, Inc · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The use of MDS to access the presence of melanoma in the skin.
Detailed description
A topical agent is applied to suspicious skin lesions and imaged. The images are analyzed to provide a score that correlates with the probability for the presence of melanoma in the lesion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MDS | Patients with a suspicious lesion, referred for a biopsy is tested using MDS. |
Timeline
- Start date
- 2017-08-30
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2014-07-17
- Last updated
- 2018-02-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02193581. Inclusion in this directory is not an endorsement.